Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
0,0050 CA$
0,00%
(0,00) 1D
28 հոկ, 13:31:29 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
285,35 հզր
Avg. vol.
773,00
Volume
0,00
52-wk high
0,01 CA$
52-wk low
0,00 CA$
EPS
-0,00 CA$
Beta
14,27
Shares outstanding
57,07 մլն
Mkt. cap
285,35 հզր
Avg. vol.
773,00
Volume
0,00
52-wk high
0,01 CA$
52-wk low
0,00 CA$
EPS
-0,00 CA$
Beta
14,27
Shares outstanding
57,07 մլն
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
HeadquartersՎանքուվեր, Բրիտանական Կոլումբիա, Կանադա
SectorHealth Care
Industry-
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34,77 հզր
2,06 հզր
2,95 հզր
1,58 հզր
Operating expense
34,77 հզր
2,06 հզր
2,95 հզր
1,58 հզր
Total operating expenses
34,77 հզր
2,06 հզր
2,95 հզր
1,58 հզր
Operating income
-34,77 հզր
-2,06 հզր
-2,95 հզր
-1,58 հզր
Other non operating income
-2,27 հզր
-1,16 հզր
-10,54 հզր
-1,91 հզր
EBT including unusual items
-39,64 հզր
-5,83 հզր
-16,55 հզր
-6,82 հզր
EBT excluding unusual items
-39,64 հզր
-5,83 հզր
-16,55 հզր
-6,82 հզր
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39,64 հզր
-5,83 հզր
-16,55 հզր
-6,82 հզր
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2,61 հզր
-2,61 հզր
-3,06 հզր
-3,33 հզր
Net interest expenses
-2,61 հզր
-2,61 հզր
-3,06 հզր
-3,33 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,38 հզր
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps